Brain, Vol. 122, No. 1, 27-39,
January 1999
© 1999 Oxford University Press
Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders
1 Department of Neurology and the Cotzias Laboratory of Neuro-Oncology and 2 Department of Pathology, Memorial Sloan-Kettering Cancer Center, 3 Department of Neurology and Neuroscience, Cornell University Medical College, 4 Department of Neurology, Neurological Institute, Columbia Presbyterian Medical Center, New York and 5 Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA
Correspondence to:
Myrna R. Rosenfeld, MD, Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA E-mail: rosenfem{at}mskcc.org
The identification of antineuronal antibodies has facilitated the diagnosis of paraneoplastic neurological disorders and the early detection of the associated tumours. It has also led to the cloning of possibly important neuron-specific proteins. In this study we wanted to identify novel antineuronal antibodies in the sera of patients with paraneoplastic neurological disorders and to clone the corresponding antigens. Serological studies of 1705 sera from patients with suspected paraneoplastic neurological disorders resulted in the identification of four patients with antibodies that reacted with 37 and 40 kDa neuronal proteins (anti-Ma antibodies). Three patients had brainstem and cerebellar dysfunction, and one had dysphagia and motor weakness. Autopsy of two patients showed loss of Purkinje cells, Bergmann gliosis and deep cerebellar white matter inflammatory infiltrates. Extensive neuronal degeneration, gliosis and infiltrates mainly composed of CD8+ T cells were also found in the brainstem of one patient. In normal human and rat tissues, the anti-Ma antibodies reacted exclusively with neurons and with testicular germ cells; the reaction was mainly with subnuclear elements (including the nucleoli) and to a lesser degree the cytoplasm. Anti-Ma antibodies also reacted with the cancers (breast, colon and parotid) available from three anti-Ma patients, but not with 66 other tumours of varying histological types. Preincubation of tissues with any of the anti-Ma sera abrogated the reactivity of the other anti-Ma immunoglobulins. Probing of a human complementary DNA library with anti-Ma serum resulted in the cloning of a gene that encodes a novel 37 kDa protein (Ma1). Recombinant Ma1 was specifically recognized by the four anti-Ma sera but not by 337 control sera, including those from 52 normal individuals, 179 cancer patients without paraneoplastic neurological symptoms, 96 patients with paraneoplastic syndromes and 10 patients with non-cancer-related neurological disorders. The expression of Ma1 mRNA is highly restricted to the brain and testis. Subsequent analysis suggested that Ma1 is likely to be a phosphoprotein. Our study demonstrates that some patients with paraneoplastic neurological disorders develop antibodies against Ma1, a new member of an expanding family of `brain/testis' proteins.
Ma1; paraneoplastic; brain/testis proteins; antineuronal antibody; cerebellar degeneration
cDNA = complementary DNA; SDS = sodium dodecyl sulphate
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Takaji, Y. Komatsu, A. Watakabe, T. Hashikawa, and T. Yamamori Paraneoplastic Antigen-Like 5 Gene (PNMA5) Is Preferentially Expressed in the Association Areas in a Primate Specific Manner Cereb Cortex, December 1, 2009; 19(12): 2865 - 2879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cho, Y. Lim, and J. A. Golden SUMO Interaction Motifs in Sizn1 Are Required for Promyelocytic Leukemia Protein Nuclear Body Localization and for Transcriptional Activation J. Biol. Chem., July 17, 2009; 284(29): 19592 - 19600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L A Hoffmann, S Jarius, H L Pellkofer, M Schueller, M Krumbholz, F Koenig, W Johannis, C la Fougere, T Newman, A Vincent, et al. Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases J. Neurol. Neurosurg. Psychiatry, July 1, 2008; 79(7): 767 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cho, Y. Lim, D. Zand, and J. A. Golden Sizn1 Is a Novel Protein That Functions as a Transcriptional Coactivator of Bone Morphogenic Protein Signaling Mol. Cell. Biol., March 1, 2008; 28(5): 1565 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Pellkofer, A. S. Schubart, R. Hoftberger, N. Schutze, M. Pagany, M. Schuller, H. Lassmann, R. Hohlfeld, R. Voltz, and C. Linington Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat Brain, August 1, 2004; 127(8): 1822 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dalmau, F. Graus, A. Villarejo, J. B. Posner, D. Blumenthal, B. Thiessen, A. Saiz, P. Meneses, and M. R. Rosenfeld Clinical analysis of anti-Ma2-associated encephalitis Brain, August 1, 2004; 127(8): 1831 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bataller, D. F. Wade, F. Graus, H. D. Stacey, M. R. Rosenfeld, and J. Dalmau Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer Neurology, March 9, 2004; 62(5): 778 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Landolfi and M. Nadkarni Paraneoplastic limbic encephalitis and possible narcolepsy in a patientwith testicular cancer: Case study Neuro Oncology, July 1, 2003; 5(3): 214 - 216. [Abstract] [PDF]
|
|
|
|
|
|
S. Shams'ili, J. Grefkens, B. de Leeuw, M. van den Bent, H. Hooijkaas, B. van der Holt, C. Vecht, and P. Sillevis Smitt Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients Brain, June 1, 2003; 126(6): 1409 - 1418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bataller, D.F. Wade, G.N. Fuller, M.R. Rosenfeld, and J. Dalmau Cerebellar degeneration and autoimmunity to zinc-finger proteins of the cerebellum Neurology, December 24, 2002; 59(12): 1985 - 1987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Amato and M. P. Anderson Case 38-2001- A 51-Year-Old Woman with Lung Cancer and Neuropsychiatric Abnormalities N. Engl. J. Med., December 13, 2001; 345(24): 1758 - 1765. [Full Text] [PDF]
|
|
|
|
|
|
D. Croteau, A. Owainati, J. Dalmau, and L. R. Rogers Response to cancer therapy in a patient with a paraneoplastic choreiform disorder Neurology, August 28, 2001; 57(4): 719 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Barnett, J Prosser, I Sutton, G M Halmagyi, L Davies, C Harper, and J Dalmau Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody J. Neurol. Neurosurg. Psychiatry, February 1, 2001; 70(2): 222 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Bien, A. Schulze-Bonhage, M. Deckert, H. Urbach, C. Helmstaedter, T. Grunwald, C. Schaller, and a. C. E. Elger Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy Neurology, December 26, 2000; 55(12): 1823 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Sutton, J. Winer, D. Rowlands, and J. Dalmau Limbic encephalitis and antibodies to Ma2: a paraneoplastic presentation of breast cancer J. Neurol. Neurosurg. Psychiatry, August 1, 2000; 69(2): 266 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Gultekin, M. R. Rosenfeld, R. Voltz, J. Eichen, J. B. Posner, and J. Dalmau Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients Brain, July 1, 2000; 123(7): 1481 - 1494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Voltz, S. H. Gultekin, M. R. Rosenfeld, E. Gerstner, J. Eichen, J. B. Posner, and J. Dalmau A Serologic Marker of Paraneoplastic Limbic and Brain-Stem Encephalitis in Patients with Testicular Cancer N. Engl. J. Med., June 10, 1999; 340(23): 1788 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. O. Dalmau and J. B. Posner Paraneoplastic Syndromes Arch Neurol, April 1, 1999; 56(4): 405 - 408. [Full Text] [PDF]
|
|
|
|
|
|
K. O. Tan, K. M. L. Tan, S.-L. Chan, K. S. Y. Yee, M. Bevort, K. C. Ang, and V. C. Yu MAP-1, a Novel Proapoptotic Protein Containing a BH3-like Motif That Associates with Bax through Its Bcl-2 Homology Domains J. Biol. Chem., January 19, 2001; 276(4): 2802 - 2807. [Abstract] [Full Text] [PDF]
|
|